GenTel BioSciences, Inc. and Eprogen, Inc. Announce Partnership to Commercialize Whole Proteome Arrays

March 11, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MADISON, Wis.--(BUSINESS WIRE)--Gentel® Biosciences, a protein microarray life sciences company, announces a technology partnership with Eprogen® to create products for the discovery of new autoantibody biomarkers using whole proteome microarrays.

Twitter
LinkedIn
Facebook
Email
Print

Alliances